Your session is about to expire
← Back to Search
Nebulized Furosemide for Coronavirus (FaST-1 Trial)
FaST-1 Trial Summary
This trial will study the effects of nebulized furosemide on pulmonary inflammation in patients with COVID-19 who are intubated and on mechanical ventilation.
- Coronavirus
- Respiratory Failure
FaST-1 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FaST-1 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How can Nebulized Furosemide help patients?
"Nebulized Furosemide is commonly used to mitigate heart failure, but it can also be employed to reduce fluid retention in edema, acute pulmonary edema, and hypertensive disease."
Why did researchers design this clinical trial in this way?
"The planned intervention will be measured for its efficacy in Baseline to day 28 time frame. The success of the trial will be judged by Improvement in pulmonary gas exchange. Additionally, secondary outcomes including Inhalation adverse events, Requirement for supplemental oxygen, and Duration of ICU Stay will also be monitored."
Could you tell me how many hospitals are participating in this clinical trial?
"Currently, this study is accepting patients from University of Alberta in Edmonton, Alberta, Kingston Health Sciences Center in Kingston, Ontario, and Hôpital Maisonneuve-Rosemont in Montréal, Quebec. There are also 4 other potential locations for recruitment."
Could I be a candidate for this medical research?
"The only patients who will be accepted into this study are those with covid-19 and between the ages of 18 and 100. Furthermore, no more than 640 people can join the trial."
If a patient is below 25 years of age, can they still participate in this research?
"People aged 18 to 100 who meet the other specified inclusion criteria can apply to participate in this trial. There are 175 similar studies for people under 18 and 1145 for those over 65."
Are there any other Nebulized Furosemide studies that have been completed?
"Nebulized Furosemide was first studied in 2015 at Gregorio Maranon Hospital. As of now, there have been a total of 110 completed studies with 16 more ongoing. The majority of these live studies are situated in Edmonton, Alberta."
How many people can join this medical study at most?
"The information available on clinicaltrials.gov implies that the research team is actively seeking participants for this study. The trial was first posted on April 16th, 2021 and underwent its most recent edit on August 16th, 2022. This experiment requires 640 individuals from 4 distinct locations."
Are there any available slots for patients in this trial?
"The clinical trial is recruiting patients at 4 locations, looking for a total of 640 individuals. The study was first posted on April 16th, 2021 and edited most recently on August 16th, 2022."
Share this study with friends
Copy Link
Messenger